Neurophysiological assessment of neural network plasticity and connectivity: Progress towards early functional biomarkers for disease interception therapies in Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neuroscience and Biobehavioral Reviews

• Publication date

  2017-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neubiorev.2016.12.020PMID 28027953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology

  2017cited by this paper
• A local insult of okadaic acid in wild-type mice induces tau phosphorylation and protein aggregation in anatomically distinct brain regions

  2016cited by this paper
• 2016 Alzheimer's disease facts and figures

  2016cited by this paper
• Neuronal network disintegration: common pathways linking neurodegenerative diseases

  2016cited by this paper
• Withdrawn: Plasma concentrations of free amyloid-β cannot predict the development of Alzheimer's disease.

  2016cited by this paper
• Modeling neurodevelopmental cognitive deficits in tasks with cross‐species translational validity

  2016cited by this paper
• Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease

  2016cited by this paper
• Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo

  2016cited by this paper
• Sleep Modulation Alleviates Axonal Damage and Cognitive Decline after Rodent Traumatic Brain Injury

  2016cited by this paper
• Pharmaco-EEG Studies in Animals: An Overview of Contemporary Translational Applications

  2016cited by this paper
• Altered Intrinsic Pyramidal Neuron Properties and Pathway-Specific Synaptic Dysfunction Underlie Aberrant Hippocampal Network Function in a Mouse Model of Tauopathy

  2016cited by this paper
• Brain neural synchronization and functional coupling in Alzheimer's disease as revealed by resting state EEG rhythms.

  2016cited by this paper
• Complement and microglia mediate early synapse loss in Alzheimer mouse models

  2016cited by this paper
• Alzheimer disease: Biomarkers of AD risk — the end of the road for plasma amyloid-β?

  2016cited by this paper
• Therapeutic strategies for the treatment of tauopathies: Hopes and challenges

  2016cited by this paper
• The amyloid cascade hypothesis: are we poised for success or failure?

  2016cited by this paper
• Impairments of neural circuit function in Alzheimer's disease

  2016cited by this paper
• Engaging Research Domain Criteria (RDoC): Neurocircuitry in Search of Meaning.

  2016cited by this paper
• Adrenergic Drugs Blockers or Enhancers for Cognitive Decline ? What to Choose for Alzheimer's Disease Patients?

  2016cited by this paper
• Measuring Cortical Connectivity in Alzheimer’s Disease as a Brain Neural Network Pathology: Toward Clinical Applications

  2016cited by this paper
• Longitudinal Changes in Functional Brain Connectivity Predicts Conversion to Alzheimer’s Disease

  2016cited by this paper
• Clinical management of sleep disturbances in Alzheimer’s disease: current and emerging strategies

  2016cited by this paper
• Sleep, circadian rhythms, and the pathogenesis of Alzheimer Disease

  2015cited by this paper
• 2015 Alzheimer's disease facts and figures

  2015cited by this paper
• Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models

  2015cited by this paper
• Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC’s afferent and efferent connections

  2015cited by this paper
• EEG Spectral Features Discriminate between Alzheimer’s and Vascular Dementia

  2015cited by this paper
• Clearance systems in the brain—implications for Alzheimer disease

  2015cited by this paper
• γ-Hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer's disease.

  2015cited by this paper
• Building a roadmap for developing combination therapies for Alzheimer’s disease

  2015cited by this paper
• World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends

  2015cited by this paper
• Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study

  2015cited by this paper
• Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice.

  2015cited by this paper
• Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer’s Disease

  2015cited by this paper
• Rodent models for Alzheimer’s disease drug discovery

  2015cited by this paper
• A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus

  2015cited by this paper
• Pathological tau disrupts ongoing network activity.

  2015cited by this paper
• Clearance systems in the brain-implications for Alzheimer disease.

  2015cited by this paper
• DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study

  2015cited by this paper
• Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer's Disease

  2015cited by this paper
• Locus coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease

  2015cited by this paper
• Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

  2014cited by this paper
• Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.

  2014cited by this paper
• The dendritic hypothesis for Alzheimer's disease pathophysiology.

  2014cited by this paper
• Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease.

  2014cited by this paper
• The synaptic plasticity and memory hypothesis: encoding, storage and persistence

  2014cited by this paper
• Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer’s disease and frontotemporal lobar degeneration

  2014cited by this paper
• Tau-Mediated NMDA Receptor Impairment Underlies Dysfunction of a Selectively Vulnerable Network in a Mouse Model of Frontotemporal Dementia

  2014cited by this paper
• Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease

  2014cited by this paper
• Antiamyloid therapy for Alzheimer's disease--are we on the right road?

  2014cited by this paper
• Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease

  2014cited by this paper
• Medicines for the Mind: Policy-Based “Pull” Incentives for Creating Breakthrough CNS Drugs

  2014cited by this paper
• Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models

  2014cited by this paper
• Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

  2014cited by this paper
• Cortical EEG oscillations and network connectivity as efficacy indices for assessing drugs with cognition enhancing potential.

  2014cited by this paper
• Tau Causes Synapse Loss without Disrupting Calcium Homeostasis in the rTg4510 Model of Tauopathy

  2013cited by this paper
• Sleep Facilitates Clearance of Metabolites from the Brain: Glymphatic Function in Aging and Neurodegenerative Diseases

  2013cited by this paper
• Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers

  2013cited by this paper
• Alterations in hippocampal network oscillations and theta–gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease

  2013cited by this paper
• Sleep Drives Metabolite Clearance from the Adult Brain

  2013cited by this paper
• Biomarkers in Alzheimer's disease with a special emphasis on event-related oscillatory responses.

  2013cited by this paper
• A phase 3 trial of semagacestat for treatment of Alzheimer's disease.

  2013cited by this paper
• Sleep deprivation before stroke is neuroprotective: a pre-ischemic conditioning related to sleep rebound.

  2013cited by this paper
• Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid

  2013cited by this paper
• Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage

  2013cited by this paper
• Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease

  2013cited by this paper
• TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer Cells

  2012cited by this paper
• Aberrant Dendritic Excitability: A Common Pathophysiology in CNS Disorders Affecting Memory?

  2012cited by this paper
• The ageing cortical synapse: hallmarks and implications for cognitive decline

  2012cited by this paper
• Lessons from Tau-Deficient Mice

  2012cited by this paper
• Impaired LTP- but not LTD-Like Cortical Plasticity in Alzheimer's Disease Patients

  2012cited by this paper
• Sleep deprivation has a neuroprotective role in a traumatic brain injury of the rat.

  2012cited by this paper
• A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β

  2012cited by this paper
• Translating long-term potentiation from animals to humans: a novel method for noninvasive assessment of cortical plasticity.

  2012cited by this paper
• Reactivity of Cortical Alpha Rhythms to Eye Opening in Mild Cognitive Impairment and Alzheimer's Disease: an EEG Study

  2011cited by this paper
• Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

  2011cited by this paper
• Default mode network connectivity in stable vs progressive mild cognitive impairment

  2011cited by this paper
• The role of phase synchronization in memory processes

  2011cited by this paper
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Resting State Cortical Rhythms in Mild Cognitive Impairment and Alzheimer's Disease: Electroencephalographic Evidence

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease

  2011cited by this paper
• The pathological process underlying Alzheimer’s disease in individuals under thirty

  2011cited by this paper
• Hippocampal synaptic plasticity in Alzheimer’s disease: what have we learned so far from transgenic models?

  2011cited by this paper
• Intrahemispheric, interhemispheric, and distal EEG coherence in Alzheimer's disease.

  2011cited by this paper
• The functional role of cross-frequency coupling.

  2010cited by this paper
• Evoked and event related coherence of Alzheimer patients manifest differentiation of sensory-cognitive networks.

  2010cited by this paper
• Selecting a mouse model of Alzheimer's disease.

  2010cited by this paper
• 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.

  2010cited by this paper
• Long-term potentiation (LTP) of human sensory-evoked potentials.

  2010cited by this paper
• Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine

  2010cited by this paper
• Animal models of amyloid‐β‐related pathologies in Alzheimer’s disease

  2010cited by this paper
• Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicity

  2010cited by this paper
• Tuning arousal with optogenetic modulation of locus coeruleus neurons

  2010cited by this paper
• Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid &bgr; After a Single Administration of an Amyloid &bgr; Monoclonal Antibody in Subjects With Alzheimer Disease

  2010cited by this paper
• Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks

  2010cited by this paper
• Prion-like transmission of protein aggregates in neurodegenerative diseases

  2010cited by this paper
• Of Mice and Men

  2009cited by this paper
• Bridging the Translational Disconnect in CNS Drug Discovery

  2009cited by this paper
• Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy

  2009cited by this paper

• Association of functional brain alterations with β-amyloid, tau, and cognitive decline in Alzheimer's disease.

  2026cites this paper
• Deep brain stimulation-induced normalization of hippocampal synchrony in a transgenic rat model of Alzheimer's disease

  2025cites this paper
• Premenstrual dysphoric disorder as a potential predisposing factor for Alzheimer’s disease: a review

  2025cites this paper
• Accelerated intermittent theta burst stimulation combined with cognitive training modulates cortical plasticity and brain activation in patients with amnestic mild cognitive impairment.

  2025cites this paper
• Investigating Communication Dynamics in Neuronal Network using 3D Gold Microelectrode Arrays

  2024cites this paper
• Efficacy and safety of repetitive Transcranial Magnetic Stimulation and transcranial Direct Current Stimulation in memory deficits in patients with Alzheimer's disease: Meta-analysis and systematic review

  2024cites this paper
• Disruption of hippocampal-prefrontal neural dynamics and risky decision-making in a mouse model of Alzheimer’s disease

  2024cites this paper
• Association of plasma amyloid-β oligomerization with theta/beta ratio in older adults

  2023cites this paper
• EEG Source Localization Based Regional-Marker for Impairment Prediction in Alzheimer's Disease

  2023cites this paper
• Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer’s Disease

  2023cites this paper
• Theta Band-Power Shapes Amyloid-Driven Longitudinal EEG Changes in Elderly Subjective Memory Complainers At-Risk for Alzheimer’s Disease

  2022cites this paper
• Understanding the neurophysiological consequences of Alzheimer’s disease pathology

  2022cites this paper
• Theta band-power shapes amyloid-driven longitudinal EEG changes in pre-clinical Alzheimer’s Disease

  2022influential citation
• The Dark Side of Alzheimer’s Disease: Neglected Physiological Biomarkers of Brain Hyperexcitability and Abnormal Consciousness Level

  2022cites this paper
• Quantitative electroencephalography changes in patients with mild cognitive impairment after choline alphoscerate administration.

  2022cites this paper
• Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets

  2022cites this paper
• β Bursting in the Retrosplenial Cortex Is a Neurophysiological Correlate of Environmental Novelty Which Is Disrupted in a Mouse Model of Alzheimer's Disease

  2022cites this paper
• Sleep, neuronal hyperexcitability, inflammation and neurodegeneration: does early chronic short sleep trigger and is it the key to overcoming Alzheimer's disease?

  2021cites this paper
• Cortical plasticity is correlated with cognitive improvement in Alzheimer's disease patients after rTMS treatment.

  2021cites this paper
• Molecular Factors Mediating Neural Cell Plasticity Changes in Dementia Brain Diseases

  2021cites this paper
• Beta bursting in the retrosplenial cortex is a neurophysiological correlate of environmental novelty which is disrupted in a mouse model of Alzheimer’s disease

  2021cites this paper
• Nipping Diseases in the Bud? Ethical and Social Considerations of the Concept of ‘Disease Interception’

  2021cites this paper
• Amyloid and anatomical correlates of executive functioning in middle-aged offspring of patients with late-onset Alzheimer's disease.

  2021cites this paper
• Functional Neurophysiological Biomarkers of Early-Stage Alzheimer’s Disease: A Perspective of Network Hyperexcitability in Disease Progression

  2021influential citation
• GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment

  2020cites this paper
• Functional Alterations in the Olfactory Neuronal Circuit Occur before Hippocampal Plasticity Deficits in the P301S Mouse Model of Tauopathy: Implications for Early Diagnosis and Translational Research in Alzheimer’s Disease

  2020cites this paper
• Sensory perceptual paradigms as a window into brain health and disease: In vivo assays of cortical plasticity and excitation-inhibition balance

  2019cites this paper
• Global EEG coherence as a marker for cognition in older adults at risk for dementia.

  2019cites this paper
• What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons.

  2019influential citation
• Early Electrophysiological Disintegration of Hippocampal Neural Networks in a Novel Locus Coeruleus Tau-Seeding Mouse Model of Alzheimer's Disease

  2019cites this paper
• Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment

  2018cites this paper
• Neuroprotective effect of paeoniflorin on okadaic acid-induced tau hyperphosphorylation via calpain/Akt/GSK-3β pathway in SH-SY5Y cells.

  2018cites this paper
• Electrophysiological Markers of Sensory Plasticity and Connectomics in Ageing and Mild Cognitive Impairment

  2018cites this paper
• Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?

  2018cites this paper
• Cholinergic Mechanisms of Target Oddball Stimuli Detection: The Late “P300-Like” Event-Related Potential in Rats

  2018cites this paper
• BDNF Val66Met Polymorphism and Gamma Band Disruption in Resting State Brain Functional Connectivity: A Magnetoencephalography Study in Cognitively Intact Older Females

  2018cites this paper
• Ameliorative Effect of Silymarin on Scopolamine-induced Dementia in Rats

  2018cites this paper
• Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer’s Disease

  2017cites this paper
• Indexing sensory plasticity: Evidence for distinct Predictive Coding and Hebbian Learning mechanisms in the cerebral cortex

  2017cites this paper